key: cord-0748856-2petlqyd authors: He, Zhigang; Xiang, Hongbing; Manyande, Anne; Xu, Weiguo; Fan, Li; Xiang, Boqi title: Epidemiological Characteristics of Sporadic Nosocomial COVID-19 Infections From June 2020 to June 2021 in China: An Overview of Vaccine Breakthrough Infection Events date: 2021-10-28 journal: Front Med (Lausanne) DOI: 10.3389/fmed.2021.736060 sha: e4c8e967a59fc87ef4bcd60e5d81317826ea6fef doc_id: 748856 cord_uid: 2petlqyd The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic has wreaked havoc on millions of people around the world. Although China quickly brought the Coronavirus disease (COVID-19) under control, there have been several sporadic outbreaks in different regions of China since June 2020. This article described the chronological nosocomial COVID-19 infection events related to several sporadic outbreaks of SARS-CoV-2 in different regions of China. We have reported epidemiological characteristics and management measures of sporadic nosocomial COVID-19 infections from June 2020 to June 2021 and specially focused on the domestic COVID-19 breakthrough infection in China, such as domestic COVID-19 breakthrough infection—a vaccinated healthcare professional working in the isolation ward of a designated COVID-19 hospital. The outbreak of the Coronavirus-2019 (COVID- 19) virus was first reported in Wuhan, China, in December 2019. The COVID-19 pandemic led China to quarantine the population to protect them (1) . Chinese authorities decided to adopt extraordinary measures to contain and limit the spread of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus. From January 1, 2020, to April 8, 2020, >8,000 patients with COVID-19 were hospitalized, and the Chinese government imposed the Wuhan lockdown on January 23, which ended on April 8, 2020 . With the COVID-19 epidemic quickly under control in the early stages of 2020, importing the SARS-CoV-2 virus could pose great challenges to the control and prevention of nosocomial COVID-19 infection in healthcare settings. Our previous report showed the impact of the novel coronavirus SARS-CoV-2 among healthcare workers in hospitals during the early phase of the COVID-19 epidemic (2) and suggested that local authorities need to be extremely cautious and implement stringent protective measures to safeguard healthcare workers to counteract the threats brought by the pandemic (3) (4) (5) . Though medical staff belongs to the susceptible population to a certain extent, hospitals have practiced cohorting in accordance with recommendations from COVID-19 infection prevention and control professional societies, which has reduced the risk of hospital-acquired COVID-19. Because healthcare workers are at the interface between hospitals and the community, where there is significant COVID-19 transmission, they may be infected by asymptomatic carriers with COVID-19 or patients with COVID-19. Furthermore, in the designated hospital admitting patients with COVID-19 or asymptomatic carriers, medical staff is highly exposed to nosocomial COVID-19 acquisition and SARS-CoV-2 transmission. Therefore, healthcare staff may play a key role in initiating or amplifying sporadic COVID-19 outbreaks in healthcare settings, such as hospitals and other care facilities. The importing of the SARS-CoV-2 virus from overseas induced sporadic outbreaks with COVID-19 from June 2020 to June 2021 in China (6, 7) . This article describes the chronological events that led to several sporadic nosocomial COVID-19 infections in different regions of China from June 2020 to June 2021, such as domestic COVID-19 breakthrough infection-a vaccinated healthcare professional working in the isolation ward of a designated COVID-19 hospital (8) . Lastly, we provide an overview of the local COVID-19 outbreak induced by the B.1.617.2 (Delta) variant of the COVID-19 virus in China. From the beginning of June 1, 2020, every day, we prospectively focused on the COVID-19 epidemic data from the Chinese Center for Disease Control and Prevention. Once we had the new report of nosocomial COVID-19 infection in China, we tracked this epidemic and collected its epidemiological characteristics from announcements by the local Health Commission, and presented narrative research for geographical and epidemiological characteristics of nosocomial COVID-19 infection from June 2020 to June 2021. We searched epidemiologic data published on the website of WHO, the China Center for Disease Control and Prevention, the National Health Commission, the Health Commission of Qingdao, Shenyang, Shijiazhuang, and Dalian city, Jilin, Shaanxi, and Guangdong Province from June 2020 to January 2021. Using the keywords "nosocomial infection, " "COVID-19 variant, " "SARS-CoV-2, " "B1.617.2 (Delta) lineage, " and Boolean operator "AND, " we periodically searched the published medical literature using the PubMed service maintained by the U.S. National Library of Medicine of NIH. Confirmed COVID-19 cases are defined as persons who tested positive for SARS-CoV-2 and had clinical symptoms. Asymptomatic carriers refer to persons without clinical symptoms who tested positive for SARS-CoV-2. From June 2020 to June 2021, the regional distribution of the sporadic nosocomial COVID-19 infections is shown in Figures 1, 2 and Table 1 . Most of these cities are located in coastal or airline hub areas, for example, Dalian, Qingdao, Shanghai are coastal cities, and Xi'an, Shenyang, Shijiazhuang, and Guangzhou are airline hub cities. Occupational Distribution of Nosocomial COVID-19 Infections From June 2020 to June 2021 From June 2020 to June 2021, six cities in China had reported over 45 cases with nosocomial COVID-19 infections, i.e., 39 confirmed cases and 6 asymptomatic cases ( Table 2) . Among them, nursing staff (3), doctors (6), patients (12) , accompanying staff (22) , and laboratorian (2) were diagnosed. The route of these nosocomial infections mainly included workplace accidental exposure to COVID-19, cross-infection among healthcare workers, patients, and accompanying staff. Table 2) . Gene sequencing results showed that the coronavirus found in Dalian, Shenyang, and Shijiazhuang cities is similar to the strain imported from Europe. The virus strain found in Xi'an city is a COVID-19 variant B.1.1.7 lineage, and the SARS-CoV-2 strain found in Guangzhou city is the imported virus strain B1.617.2 (Delta) lineage ( Table 2) . A report from Fang et al. (12) showed that the strains associated with a specific outbreak in Dalian City were as follows: LNDL-BHQ-0722-Y_S12_L001_R1_001, LNDL-SFL-0722-Y_S9 _L001_R1_001, LNDL-WY-0722-Y_S11_L001_R1_001, and LNDL-XY-0722-Y_S10_L001_R1_001, and the parent strain from Wuhan was NC_045512.2_Severe_acute_respiratory_s yndrome_coronavirus_2_isolate_Wuhan-Hu-1_complete_ge nome. After accessing the public database GISAID and GenBank, three Russian strains detected in July were found to share the 10 variation sites with the two Hebei strains (GISAID IDs: E PI_ISL_596266, EPI_ISL_569792, and EPI_ISL_569793) (13) . The evidence indicates that the Shijiazhuang strains may have originated from this Russian strains (13) . This study provides us with an inspiring vision regarding the current COVID-19 pandemic. The main findings of sporadic For healthcare workers, patients/accompanying staff, and cleaners, their COVID-19 infection may be from a hospital (hospital-acquired infection, also nosocomial infection) or community (community-acquired infection). Distinguishing nosocomial infection and community-acquired infection is an important base to control the epidemic in nosocomial COVID-19 infections. Because healthcare workers are at the interface between hospitals and the community, where there is significant COVID-19 transmission, they may be infected by asymptomatic carriers from the community with COVID-19 or patients with COVID-19. These healthcare workers (infected in the community) do not belong to nosocomial infection (also called hospital-acquired infection). For example, in Figure 1 , the infected cases (such as healthcare workers, cleaners, and so on) in Beijing, Dalian (December 27, 2020), and Shanghai were community-acquired infections, not nosocomial infections. For nosocomial infection of healthcare workers, patients/accompanying staff, and cleaner, the effective control measures taken by the local government must include: (1) these hospitals imposed lockdown, especially in the designated COVID-19 hospital; (2) rolling out an overall nucleic acid test campaign to all staff is key in healthcare settings. Among nine sporadic nosocomial COVID-19 infections, our results showed that eight series cases were found by rolling out overall a nucleic acid test campaign to all hospital staff, suggesting the importance of regular screening for all staff in healthcare settings. As part of efforts to control the COVID-19 infections, one of the effective prevention measures taken by local authorities is that all hospital personnel labeled a key population is closely monitored (7) . Whether the epidemic in nosocomial COVID-19 infections can be brought under control depends on how many new infections emerge of their close contacts and secondary close contacts in the next 2 weeks. If these hospitals imposed lockdown as the effective control measures taken by the local government, then ideally, new confirmed cases with COVID-19 infections will see a downward trend within 2 weeks. Cases, such as hospital-acquired infection in the designated hospital of Qingdao city, are a warning that workplace storage and transport could be a hotbed for the coronavirus or other pathogens. There is an urgent demand for workplace disinfection to protect the health safety of medical staff, patients, and accompanying staff in the current pandemic or into another worse outbreak. Our data also showed that a vaccinated healthcare professional who received inactivated vaccine was infected with COVID-19 while working in the isolation ward of a designated COVID-19 hospital, and the coronavirus strain was determined to be the imported COVID-19 variant strain B.1.1.7 (8) , suggesting that there exists the domestic COVID-19 vaccine breakthrough infection in China, and this phenomenon deserves our serious attention. Vaccination is well-known to be key to stopping the virus from circulating and more variants from popping up (14) (15) (16) . The vaccine breakthrough infection case was defined as an individual with positive SARS-CoV-2 nucleic acid amplification tested after receiving at least one dose of a SARS-CoV-2 vaccine Vaccine breakthrough cases with SARS-CoV-2 were reported in many countries (22) (23) (24) . An analysis from the vaccination campaign of Israel showed that COVID-19-related hospitalizations, severe disease, and death were reduced in infected cases with SARS-CoV-2 after vaccination, such as symptomatic and asymptomatic infections (24). Antonelli et al. (25) identified risk factors for post-vaccination SARS-CoV-2 infection and describe the characteristics of post-vaccination illness and found that Almost all symptoms were reported less frequently in infected vaccinated individuals than in infected unvaccinated individuals, and vaccinated participants were more likely to be completely asymptomatic, especially if they were 60 years or older. Our vaccine breakthrough case from Xi'an supported vaccine effectiveness and cautioned around relaxing physical distancing and other personal protective measures in the post-vaccination era. Severe acute respiratory syndrome coronavirus 2 virus delta variants have drawn worldwide attention. The WHO proposed three labels for global SARS-CoV-2 variants, namely, a variant of concern (VOC), variant of interest (VOI), and variant under monitoring, to be used alongside the scientific nomenclature in communications about variants to the public (26) . The B.1.617 (28) . The WHO declared the delta variant a "VOC" on May 10, 2021. In mid-June 2021, the US Centers for Disease Control and Prevention upgraded its classification of the delta from a "VOI" to a "VOC" (29) . Our results showed that two medical staff (one laboratorian and one emergency doctor), infected with COVID-19 in the designated hospital, occurred due to workplace accidental exposure to COVID-19, and the coronavirus strain was determined to be the imported B.1.617.2 (Delta) variant. To conclude, our findings add to the accumulating evidence regarding the importance of regular screening for all staff in healthcare settings. Furthermore, our study highlights the need for an update of the current hospital disinfection procedures in designated hospitals to prevent the nosocomial spread of SARS-CoV-2 infection. Finally, the epidemiological exposure of vaccinated medical staff should draw concern to minimize the impact of a new outbreak induced by virus mutants. The original contributions presented in the study are included in the article/supplementary material, further inquiries can be directed to the corresponding author/s. All the authors contributed to the paper's presented methodology, conceptualization, data analysis, and paper writing. Geographical and epidemiological characteristics of 3,487 confirmed cases with COVID-19 among healthcare workers in China The impact of novel coronavirus SARS-CoV-2 among healthcare workers in hospitals: an aerial overview Nosocomial transmission and outbreaks of coronavirus disease 2019: the need to protect both patients and healthcare workers COVID-19 healthcare policies in Ireland: a rapid review of the initial pandemic response Risk factors of healthcare workers with coronavirus disease 2019: a retrospective cohort study in a designated hospital of Wuhan in China Geographical and epidemiological characteristics of sporadic coronavirus disease 2019 Occupational characteristics and management measures of sporadic COVID-19 outbreaks from Outbreak reports: mild breakthrough infection in a healthcare professional working in the isolation area of a hospital designated for Treating COVID-19 patients -Shaanxi Province Cold-chain food contamination as the possible origin of COVID-19 resurgence in Beijing Cold-chain transportation in the frozen food industry may have caused a recurrence of COVID-19 cases in destination: successful isolation of SARS-CoV-2 virus from the imported frozen cod package surface Virus found in Hebei similar to Russian strain: China CDC A case of COVID-19 detected in a cargo worker at pudong airport -Shanghai Municipality, China Two reemergent cases of COVID-19-Hebei Province COVID-19 vaccines: rapid development, implications, challenges and future prospects SARS-CoV-2 disease through viral genomic and receptor implications: an overview of diagnostic and immunology breakthroughs COV2.S protects Syrian hamsters against G614 spike variant SARS-CoV-2 and does not enhance respiratory disease. npj Vaccines Transmission of SARS-CoV-2 variant B.1.1.7 among vaccinated health care workers Vaccine breakthrough infections with SARS-CoV-2 variants REPLY Evidence for increased breakthrough rates of SARS-CoV-2 variants of concern in BNT162b2-mRNA-vaccinated individuals Post-vaccination SARS-CoV-2 infections and incidence of the B.1.427/B.1.429 variant among healthcare personnel at a northern California academic medical center Vaccine breakthrough infections with SARS-CoV-2 variants Vaccine side-effects and SARS-CoV-2 infection after vaccination in users of the COVID Symptom Study app in the UK: a prospective observational study Effectiveness of the Pfizer-BioNTech and Oxford-AstraZeneca vaccines on covid-19 related symptoms, hospital admissions, and mortality in older adults in England: test negative case-control study Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel: an observational study using national surveillance data Risk factors and disease profile of post-vaccination SARS-CoV-2 infection in UK users of the COVID Symptom Study app: a prospective, community-based, nested, case-control study WHO Narrows in on Delta COVID Variant Delta COVID-19 Variant Is Now in More Than 80 Countries US CDC Has Declared Coronavirus Delta Variant A 'Variant of Concern The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.